Corona UpdatesNews

UAE research institute developes a breakthrough treatment for COVID-19

The Abu Dhabi Stem Cells Center (ADSCC) has developed an innovative method

UAE-researchThe announcement of the major development was made by UAE's Director of Strategic Communications - OyeYeah News
Views

A UAE research institute has developed a breakthrough treatment for COVID-19 which could be a game-changer in the global fight against the virus.

The announcement of the major development was made by UAE’s Director of Strategic Communications, Ministry of Foreign Affairs.

The Abu Dhabi Stem Cells Center (ADSCC) has developed an innovative method that involves extracting stem cells from a patient’s blood and reintroducing them into the lungs via inhalation of a mist, regenerating lung cells and preventing the immune system from overreacting, says the statement.

As per the statement, the treatment has already successfully undergone an initial phase of clinical trials – with 73 patients making full recoveries without any adverse side effects. The recipients were moderately or severely ill before treatment, with many intubated in an ICU.

More trials are being conducted and we should have a clearer understanding of the treatment’s potential in the coming weeks, but it could have a significant impact on our ability to live with the virus until a vaccine is available.

The ADSCC effort is one of around 60 significant studies in the UAE aiming to produce COVID-19 treatments and improve testing, in line with the UAE Government’s determination to mobilize the country’s resources towards overcoming the virus, concluded the statement. 

the authorSaman Siddiqui
Saman Siddiqui, A freelance journalist with a Master’s Degree in Mass Communication and MS in Peace and Conflict Studies. Associated with the media industry since 2006. Experience in various capacities including Program Host, Researcher, News Producer, Documentary Making, Voice Over, Content Writing Copy Editing, and Blogging, and currently associated with OyeYeah since 2018, working as an Editor.